The mRNA COVID-19 vaccine has allowed us to witness the effectiveness, safety, and tremendous potential of mRNA technology. Currently, research institutions worldwide are targeting cancer as the next goal for mRNA technology.Read More…
Nature: Development of a New Oral Vaccine to Help Eradicate Polio
Despite conducting some of the most successful international vaccination campaigns in history, the poliovirus continues to circulate worldwide, posing a threat of neurological damage and paralysis to unvaccinated individuals. While wild poliovirusRead More…
Advanced Science: Cancer Vaccine Based on Tumor Cells or Tumor Cell/Tissue Lysate
Cancer vaccines are one of the most important methods of cancer immunotherapy. The three main factors that determine the efficacy of cancer vaccines are antigen, adjuvant, and formulation. Antigens induce specific immuneRead More…
JEM: Scientists use “Natural Systems” to Identify Specific Proteins that Have the Potential to Develop an Efficient HIV Vaccine
According to WHO data, since the identification of the cause of acquired immunodeficiency syndrome (AIDS) in 1984, the human immunodeficiency virus (HIV) has infected more than 80 million people and caused 40Read More…
The Protection Mechanism of mRNA Vaccines Against Monkeypox Virus
Recently, SCIENCE CHINA Life Sciences published a collaborative research paper entitled “Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity”. In this study,Read More…
The Research Progress of Multi-Antigen Monkeypox mRNA Vaccine
Monkeypox, a zoonotic disease, was first found in monkeys used in the study in 1958 and spread mainly in animals. Human monkeypox cases were first found in the Democratic Republic of theRead More…
The World’s First RSV Vaccine Has Been Approved
GSK announced that its respiratory syncytial virus (RSV) vaccine Arexvy (RSVPreF3 OA/GSK3844766A) has been approved by the FDA for the prevention of lower respiratory disease (RSV-LRTD) caused by RSV infection in theRead More…
A New Breakthrough in Cancer Vaccine: Transforming Cancer Cells into Anticancer Vaccine
Therapeutic tumor cells (ThTCs) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This strategy has been proven to induce an anti-tumor immune responseRead More…
Interpretation of the Latest Research on the Immunogenicity of the Monkeypox mRNA Vaccine
Monkeypox virus (monkeypox, MPXV) was first identified in non-human primates in the late 1950s. Monkeypox, a zoonotic disease, was first found in monkeys used in the study in 1958 and spread mainlyRead More…
New Breakthroughs in Cancer Vaccine
Therapeutic tumor cells (ThTC) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This method has been shown to trigger the transfer of powerfulRead More…